Up to $100 million in additional loan proceeds provide additional financial flexibility to advance detalimogene development ...
New January-February Edition Highlights Transparent Insights on Cost Plus Drugs and the Future of Community Pharmacy PITTSBURGH, PENNSYLVANIA / ACCESS Newswire / January 21, 2026 / Dispense Times, a ...
Sixth overall for Lantern’s A.I.-driven precision oncology pipelineOrphan designation expands LP-284's potential for an ...
IMMUNOLIFE, a Phase 2 randomized exploratory study, will evaluate the potential of MaaT033 in combination with Cemiplimab ...
Following discussions with the U.S. FDA, the Agency recommended that the Company submit additional information for its ...
Agreement comes on the heels of Company inking an exclusive distribution agreement with Gulf Medical for Saudi ArabiaCreates ...
Crown Bioscience, a global contract research organization (CRO) and a JSR Life Sciences company, today announced that its San ...
Davos: Investing in small scale farmers and rural entrepreneurs is a compelling business case and a geostrategic ...
Cox, Castle & Nicholson LLP, a leading full-service law firm specializing in real estate in the United States, announced ...
Oral presentation to highlight first-ever clinical evidence supporting use of a targeted GYS1 substrate reduction therapy, ...
OPEX® Corporation, a global leader in Next Generation Automation providing innovative solutions for warehouse, document and ...
Conference Call and Webcast Scheduled for 1:30 p.m. PTALISO VIEJO, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback